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Mucinous adenocarcinoma (MAC) is commonly found in the gastrointestinal tract but
head and neck localisations are very rare. This article presents the case of a 67-year-
old patient suffering from a minor salivary gland MAC of the left buccal mucosa, who
was treated in the Department of Cranio-Maxillofacial Surgery in Krakow due to mul-
tiple recurrences of the tumour. The results of immunohistochemical staining, the course
of surgical treatment and follow-up, as well as a review of literature are also discussed.
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Introduction
Mucinous adenocarcinoma (MAC) is most fre-
quently observed in the digestive organs. The most com-
mon localisation is the large intestine (colon), and it is
estimated that MAC constitutes 10-20% of colorectal
cancers, followed by the pancreas, ovary, lung, prostate,
and breast [1]. The primary head and neck localisation
of MAC is very rare and accounts for about 3% of sali-
vary gland tumours. Salivary gland MACs are charac-
terised by high aggressiveness due to a high rate of lo-
cal recurrences and nodal metastasis [1-3].
The tumour is composed of large extracellular
mucin pools and irregular-shaped neoplastic epithelial
cells surrounded by numerous cystic cavities, separat-
ed by fibrous strands. The cancer cells have clear cyto-
plasm and small, round, darkly-stained nuclei. The tu-
mour cells form nests embedded in the extracellular
mucin pools [3-7]. According to some authors the his-
tological features are so characteristic that differential
diagnosis from other malignant salivary gland tumours
is straightforward [5]. On the other hand, there are au-
thors who regard MAC’s recognition criteria as con-
troversial and inconclusive [3, 6, 8]. According to the
WHO, the microscopic image is dominated by small
foci of cancer cells or even single cells surrounded by large
areas of extracellular mucin separated by connective fi-
brous strands. In addition, at least half of the tumour
cells should produce mucus [8]. Histologically, MAC
may be confusingly similar to the mucinous eccrine car-
cinoma of the skin, mucinous carcinoma of the breast
and colloid carcinoma of the bowel [7]. An important
feature of MAC are mucus-producing cells which
show positive staining for mucicarmine and Alcian blue.
However, these cells are also characteristic for other sali-
vary gland tumours; hence immunohistochemical
(IHC) staining is helpful in differential diagnosis. Typ-
ical for MAC is a strongly positive reaction for cytok-
eratins (CK) AE1/AE3,7, intermediate or strong reac-
tion for CK 8, 18, 19, positive reaction for epithelial
membrane antigen (EMA), vimentin, carcinoembryonic
antigen (CEA), and varied reaction with α-SMA
(smooth muscle actin), α-amylase and calcitonin. Cy-
tokreatins, vimentin, S-100 protein, and α-SMA pos-
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itive staining is characteristic for most salivary gland tu-
mours [3, 4, 6]. Some authors believe that the positive
reaction for neuron specific enolase (NSE), calcitonin and
somatostatin may be the evidence of neuroendocrine dif-
ferentiation, but the exact significance of this expres-
sion is unknown [8]. Primary minor salivary gland MAC
requires exclusion of metastatic nature of the tumour.
An important feature of salivary gland MACs is a clear
difference in the number of chromosomal aberrations
in comparison with MAC of digestive organs [1].
Case report
A 67-year-old patient reported to the Outpatient
Unit of the Department of Cranio-Maxillofacial Sur-
gery due to a large tumour involving the left half of
the face. The lesion had been observed by the patient
for about 12 years, originally removed as an epidermal
cyst of the left cheek in the regional hospital. Three years
later a recurrent tumour in the postoperative scar was
removed. The histological examination revealed ge-
latinous adenocarcinoma, most likely arising from a mi-
nor salivary gland of the oral mucosa; the lesion was
excised without adequate margins. The patient was con-
sulted in the Department of Oncology but due to the
radioresistance of the tumour he was disqualified from
adjuvant radiotherapy and was admitted to our de-
partment in order to extend the surgical resection. In
1997 the excision of the tumour of the left infraorbital
area with resection of the underlying bone was per-
formed; the defect was reconstructed by the frontal flap.
The margins of resection were positive; thus an addi-
tional extended excision of the postoperative scar was
carried out. This time there were no signs of the tu-
mour in the histopathological examination. In 1999 the
next excision of the local recurrence was carried out,
and the histological examination indicated radical ex-
cision. In 2007 the patient reported again to our de-
partment with the suspicion of local recurrence in the
left cheek but did not consent to the proposed surgery
and avoided follow-up examination until 2012, when
the patient reappeared, presenting an extensive tumour
involving the whole left half of the face infiltrating the
orbit, infraorbital area, left cheek as well as masseteric
area and submandibular region on the left side (Fig.
1, 2). The range of the tumour was confirmed in CT
of the facial part of the skull (Fig. 3, 4). Diagnostic biop-
sy was performed. During collection of the diagnostic
material, a jelly-like consistency of the tumour could
be observed with an abundant outflow of mucus. The
results of basic blood tests revealed no abnormalities.
The ultrasound examination of the abdomen and
Fig. 1. The patient with minor salivary gland MAC of the
buccal mucosa infiltrating the left half of the face
Fig. 2. The same patient – lateral view
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X-ray image of the chest revealed no distant metastases.
The histological result of the biopsy of the tumour of
the left cheek revealed recurrent mucinous adenocar-
cinoma G1 with cancer cells of medium size, with
a slightly basophilic cytoplasm and oval nuclei. The can-
cer cells were arranged in small concentrations and
patches embedded in mucus, divided into small cav-
ities (Fig. 5, 6). The cells presented the following pat-
tern of IHC reactivity: CK: AE1/AE3, CK19 positive
reactions in the cancer cells; in contrast, CK5/6,
CK5/6/18, and SMA were negative. Histochemical re-
actions – PAS, Alcian blue, mucicarmine – were pos-
itive in the cancer stroma (Fig. 7, 8). The tumour orig-
inated from a small salivary gland. Due to the severity
and advancement of the disease the patient was dis-
qualified from surgical treatment, reconsulted in the
Department of Oncology and qualified for palliative
chemotherapy.
Discussion
As a rare tumour, MAC causes difficulties in diag-
nosis [3, 5, 6, 8]. Clinical symptoms of the head and
neck MAC are uncharacteristic and diagnosis is based
on the histopathological and immunohistochemical ex-
amination. In the available literature (PubMed 1973-
2012) we have found 21 published cases of MAC aris-
ing from minor salivary glands localised in the palate
(9 cases), buccal mucosa (4 cases), floor of the mouth
(3 cases), lips (3 cases) and tongue (2 cases) [3, 6, 7, 9].
Fig. 3. The same patient – CT scan showing extension of
the tumour (horizontal view)
Fig. 4. The same patient – CT scan showing extension of
the tumour (frontal view)
Fig. 5. MAC nests within dermis. HE staining, magni-
fication 25×
Fig. 6. MAC cells in deep subcutaneous fat tissue.
HE staining, magnification 50×
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Fig. 7. MAC cells embedded in mucus – in Alcian blue
staining, magnification 50×
Fig. 8. PAS staining (mucus in pink, cell structures of the
cancer in blue), magnification 100×
Table I. Reported cases of MAC arising from minor salivary glands
REFERENCES LOCAL AGE SEX LOCALISATION CERVICAL TREATMENT FOLLOW-UP
APPEARANCE LYMPH NODE
METASTASIS
Shumway greyish tumour 72 male palate no excision + 8 months
RT
Notani ulcerated tumour 64 male palate yes RT + 6 months
maxillectomy +
ND
Gao ulcerated tumour 50 male palate yes not mentioned not mentioned
Gao ulcerated tumour 51 male palate yes not mentioned not mentioned
Gao exophytic tumour 58 female palate no not mentioned not mentioned
Gao ulcerated tumour 48 female palate yes not mentioned not mentioned
Gao tumour 70 male floor of not not mentioned 10 months
the mouth mentioned






Seoane exophytic fibroma- 47 male palate no excision not mentioned
like tumour
Aydin tumour 80 male lip not excision 6 months
mentioned
Uchida tumour 65 male ventral part no glossectomy 6 years
of the tongue
Ide tumour 1 cm 76 female lower lip no excision distant metastasis
after 6 years
Ide tumour 1.4 cm 82 female upper lip no excision local and nodal
recurrence after
3 years
Barbosa tumour 52 male floor of no RTGTH + 11 months
the mouth excision + ND
Current primarily 67 male cheek yes multiple 24 years
case tumour (43) excision
of the cheek
RT – radiotherapy, NP – neck dissection
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The data of 13 patients (reported in English-language
literature only) are presented in Table I. In the oral cav-
ity MAC appears as an exophytic, painless tumour of
various morphology which clinically may imitate ade-
noma, fibroma or pyogenic granuloma. MAC of the floor
of the mouth resembles calculus of the salivary duct. In
differential diagnosis all neoplasms with cells produc-
ing mucus should be taken into consideration, e.g. mu-
coepidermoid carcinoma, mucinous cystadenocarcino-
ma, mucin-rich salivary duct carcinoma and signet-ring
cell adenocarcinoma. An analysis of the reported cas-
es of MAC arising from minor salivary glands revealed
that the disease was characteristic for older adults (av-
erage age 57 years) with male to female ratio 2 : 1. Cer-
vical lymph node involvement at the time of initial di-
agnosis of MAC was observed in 12 patients (57.1%).
Major salivary gland MAC was reported in 9 to 14
patients (some cases might be doubled). In 5 cases the
primary tumour was localised in the submandibular
gland, in 3 to 8 cases in the parotid gland and in 1 in
the sublingual gland. The data concerning the frequency
of MAC occurrence in minor and major salivary
glands are ambiguous and indicate predominance of
MAC arising from minor salivary glands (2 : 1) [3-8].
Other atypical localisations of MAC include the nasal
cavity, paranasal sinuses and one case of a tumour of
the mandibular ramus [8].
In the currently reported case, we believe that the
tumour arising from the minor salivary gland of the buc-
cal mucosa was initially misdiagnosed as an epidermal
cyst. In our patient immunohistochemical staining re-
vealed positive reaction for CK AE1/AE3 as well as
CK19, and negative for CK5/6, CK5/6/18 and SMA.
Also positive staining for PAS, Alcian blue and muci-
carmine was obtained in mucin stroma of the cancer.
These findings correspond with the results presented
by other authors [4, 5, 7, 8].
In commonly observed cases of MAC of the diges-
tive organs well-established algorithms of therapy are
available. In the treatment of patients in stage I surgery
is the method of choice, in stages II and III surgery com-
bined with chemotherapy, whereas in stage IV surgery
combined with chemo/radiotherapy is indicated [10-13].
Based on the current literature, we conclude that the
best treatment modality in patients with MAC of the
head and neck region is surgery, comprising wide ex-
cision of the tumour with concomitant neck dissection.
Some authors stress the necessity of adjuvant radio-
therapy in these patients. As limited clinical data are
not sufficient for establishing clear indications for
chemotherapy, in patients with head and neck MAC,
the decision should be taken after an analysis of each
individual case [3, 4, 6, 7].
Conclusions
In the cases reported so far, the aggressive charac-
ter of salivary gland MAC is proved by a high rate of
cervical lymph node metastases (about 60%) present
at the initial diagnosis of the tumour as well as a high
rate of local recurrence. Such features of the tumour
as well as its radioresistance suggest that extensive ex-
cision combined with neck dissection is the optimal
treatment modality in patients with MAC of the head
and neck region. We can hypothesize that in the pre-
sented patient exceptionally long follow-up might have
been related to unique different chromosomal aber-
rations in the cancer cells. Appropriate immunohis-
tochemical profiling is mandatory for the proper
histopathological diagnosis of MAC.
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